(Q36936061)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18766191%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

title

Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18766191%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18766191%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

G McDowell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18766191%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

C N McCollum

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18766191%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

S Kumar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18766191%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

G J Byrne

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18766191%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

language of work or name

English

0 references

publication date

2 September 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18766191%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

13 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18766191%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18766191%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18766191%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

1000-1006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18766191%20AND%20SRC:MED&resulttype=core&format=json

Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey

13 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2567096

Fibrin fragment D-dimer and the risk of future venous thrombosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2567096

Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2567096

Serum vascular endothelial growth factor in breast cancer: its relation with cancer type and estrogen receptor status.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2567096

Pathogenetic mechanisms of thrombosis in malignancy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2567096

Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2567096

Prognostic significance of thrombocytosis in patients with primary lung cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2567096

Hemostatic Abnormalities in Malignancy, a Prospective Study of One Hundred Eight Patients: Part I. Coagulation Studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2567096

Hemorheologic variables in breast cancer patients at the time of diagnosis and during treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2567096

The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2567096

Chemotherapy for breast cancer decreases plasma protein C and protein S.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2567096

Heparin abolishes the chemotherapy-induced increase in plasma fibrinopeptide A levels.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2567096

Procoagulant activity in whole blood from patients with breast and colorectal cancer.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2567096

Coagulation-fibrinolysis system and markers of collagen metabolism in lung cancer.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2567096

Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2567096

Haemostatic changes; plasma levels of alpha2-antiplasmin-plasmin complex and thrombin-antithrombin III complex in female breast cancer

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2567096

The effect of very-low-dose warfarin on markers of hypercoagulation in metastatic breast cancer: results from a randomized trial.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2567096

Coagulation activation markers in the prediction of venous thrombosis after elective hip surgery.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2567096

Blood coagulation during adjuvant epirubicin/cyclophosphamide chemotherapy in patients with primary operable breast cancer

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2567096

Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2567096

Pre-operative plasma levels of thrombin-antithrombin III complexes correlate with the development of venous thrombosis after major hip or knee surgery

4 September 2018

1 reference

12 December 2020

Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patients

1 reference

12 December 2020

Effects on blood coagulation of adjuvant CNF (cyclophosphamide, novantrone, 5-fluorouracil) chemotherapy in stage II breast cancer patients

1 reference

12 December 2020

The natural history and aetiology of deep vein thrombosis after total hip replacement

1 reference

12 December 2020

Venous thrombosis during multimodal treatment of primary breast carcinoma

1 reference

12 December 2020

Pre-operative plasma levels of soluble fibrin polymers correlate with the development of deep vein thrombosis after elective neurosurgery

1 reference

12 December 2020

Activation of blood coagulation and the activity of cancer procoagulant (EC 3.4.22.26) in breast cancer patients

1 reference

12 December 2020

Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status

1 reference

12 December 2020

Perioperative development of a thrombogenic risk profile in patients with carcinomas of the breast: a cause of increased thrombosis

1 reference

12 December 2020

Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients

1 reference

12 December 2020

Hypercoagulable state induced by cytostatic drugs in stage II breast cancer patients

1 reference

12 December 2020

Acquired protein C deficiency in patients with breast cancer receiving cyclophosphamide, methotrexate, and 5-fluorouracil

1 reference

12 December 2020

Preoperative assessment of fragment D-dimer as a predictor of postoperative venous thrombosis

1 reference

12 December 2020

Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study

1 reference

12 December 2020

D-dimer plasma measurement in patients undergoing major hip surgery: use in the prediction and diagnosis of postoperative proximal vein thrombosis

1 reference

12 December 2020

A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy

1 reference

12 December 2020

Pre- and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease--a preliminary study

1 reference

12 December 2020

Blood coagulation and thrombosis in patients with ovarian malignancy

1 reference

12 December 2020

Prognostic impact of an activation of coagulation in lung cancer

1 reference

12 December 2020

Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables: the ECAT DVT Study. European Concerted Action on Thrombosis

1 reference

12 December 2020

Urinary tissue factor levels in patients with breast and colorectal cancer

1 reference

12 December 2020

Neither baseline tests of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical-surgical patients

1 reference

12 December 2020

Relationship of coagulation test abnormalities to tumour burden and postoperative DVT in resected colorectal cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6604620

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18766191%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18766191%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

PubMed publication ID

18766191

1 reference